The table below shows Guardant Health, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$65.62M
-$62.69M
-$30.28M
-$74.44M
-$28.62M
-$16.29M
Capital expenditure
$5.58M
$4.46M
$6.93M
$7.52M
$22.70M
$9.59M
Investing cash flow
$699.42M
$302.86M
$28.07M
$157.22M
$110.81M
$123.87M
Dividends paid
-
-
-
-
GH operating cash flow (10-K history)
Guardant Health, Inc. reported operating cash flow of -$184.76M for fiscal year 2025. That is up 23.0% from -$239.86M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$36.71M (FY 2016) to -$184.76M. Figures come from the company's audited annual reports as filed with the SEC.
